Mondido, Rogelyn G.
HRN: 25-47-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/12/2024
07/19/2024
IV
200mg
Q8hours
T/c Dengue Hemorrhagic Fever
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes